Characterization of the clinical and immunologic phenotype and management of 157 individuals with 56 distinct heterozygous NFKB1 mutations
Àngela Deyà‐Martínez, Maximilian Seidl(Heinrich Heine University Düsseldorf), J.W.M. van der Meer(Radboud University Nijmegen), M. Piquer‐Gibert(Hospital Sant Joan de Déu Barcelona), Safa Barış(Marmara University), Faranaz Atschekzei(Medizinische Hochschule Hannover), Yael Dinur Schejter(University of Toronto), Matias Kinnunen(University of Helsinki), Alessandro Plebani(University of Brescia), Polina Stepensky(Hebrew University of Jerusalem), Laia Alsina(Hospital Sant Joan de Déu Barcelona), Mohammed F. Alosaimi(Boston Children's Hospital), Manfred Fliegauf(University of Freiburg), Alla Bulashevska(University of Freiburg), Janet Chou(Boston Children's Hospital), Maria Marluce dos Santos Vilela(Universidade Estadual de Campinas (UNICAMP)), Esther de Vries(Tilburg University), Oliver Bartsch(Johannes Gutenberg University Mainz), Lauren Weintraub(Albany Medical Center Hospital), Bella Shadur(Garvan Institute of Medical Research), João Farela Neves(Unidade Local de Saúde de São José), Ute Fischer(Dortmund University of Applied Sciences and Arts), Raif S. Geha(Boston Children's Hospital), Kaan Boztuǧ(Forschungszentrum Jülich), Vassilios Lougaris(University of Brescia), N. B. Kuzmenko(Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology), V.P. Zakharova(Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology), Luís M. Allende(Hospital Universitario 12 De Octubre), Robin Kobbe(Universität Hamburg), Nadezhda Camacho-Ordóñez(University of Freiburg), Luis Alberto Pedroza(Universidad San Francisco de Quito), Timo Hautala(Oulu University Hospital), Mónica Martínez‐Gallo(Universitat Autònoma de Barcelona), Luis Ignacio González‐Granado(Research Institute Hospital 12 de Octubre), Tatjana Hirschmugl(Austrian Academy of Sciences), Nils Klammer(University of Freiburg), Chaim M. Roifman(University of Toronto), Dirk Holzinger(University of Duisburg-Essen), Michele Proietti(University of Freiburg), Peter Švec(Comenius University Bratislava), Rohan Ameratunga(Auckland City Hospital), Markku Varjosalo(University of Helsinki), Natalie Frede(University of Freiburg), Christoph Klein(Ludwig-Maximilians-Universität München), Anna Shcherbina, Michiel van der Flier(Radboud University Medical Center), Reinhold E. Schmidt(Medizinische Hochschule Hannover), Winnie Ip(Great Ormond Street Hospital), Claudia Schröder(Medizinische Hochschule Hannover)
Cited by 127
Related Papers
Defining trained immunity and its role in health and disease
|Nature reviews. Immunology|2020|2.5k
Activation-Induced Cytidine Deaminase (AID) Deficiency Causes the Autosomal Recessive Form of the Hyper-IgM Syndrome (HIGM2)
|Cell|2000|1.6k